diabetes
Alere and Former Diabetic Testing Subsidiary Settle False Claims Allegations for $160M
Now-defunct Arriva Medical and its parent company Alere were accused of paying kickbacks to Medicare beneficiaries.
GBS Gets $4.7M Australian Federal Government Grant to Expand Biosensor Manufacturing
The grant will help the company begin scaled production of its Printable Organic Electronic Biosensor technology for the Asia Pacific region.
University of Liverpool, Bard1 Life Sciences to Evaluate Diabetes Blood Test
The agreement provides Bard1 with the option to license the intellectual property for the development and evaluation of a type 3c diabetes test that uses novel protein biomarkers.
Sebia Acquires Dx Firm Orgentec Diagnostika
Orgentec Diagnostika develops and markets autoimmune and blood diagnostic tests, as well as tests for treatment-associated monitoring.
GBS, Johns Hopkins Partner to Accelerate Development of Saliva-Based Dx Tests
The program will support Johns Hopkins' research into saliva testing and diagnostics and will help GBS form its commercialization strategy for two saliva-based tests.
Nov 17, 2020
Trinity Biotech Q3 Revenues Rise 30 Percent
Apr 22, 2020
Roche Diagnostics Q1 Sales Essentially Flat
Dec 10, 2019
Roche Blood Glucose Monitor App Receives CE Mark
Oct 10, 2019
Oct 2, 2019
Sep 25, 2019
ProciseDx POC Instrument CE Marked
Aug 22, 2019